UnitedHealth Group
UnitedHealth Group Incorporated
Key figures
Period Jan 2025 to Dec 2025ConsolidatedU.S. GAAP
RevenueDisclosed
US$447.6B
Operating marginCalculated
4.2%
Net assets to total assetsCalculated
Could not be retrieved
Company profile
Tables scroll sideways
Disclosed data
Profitability
★★☆☆☆position among all companies
4.2%
Growth (revenue, 4-year average)
★★★★☆position among all companies
11.7%
Capital efficiency
Could not be retrieved
Revenue and profit
Performance, financial position and capital allocation
UnitedHealth Group
Recent performance trends
UnitedHealth Group
Cash flow trends
Consolidated indicators (8 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$287.6 billion | US$324.2 billion | US$371.6 billion | US$400.3 billion | US$447.6 billion |
| Operating income | US$24.0 billion | US$28.4 billion | US$32.4 billion | US$32.3 billion | US$19.0 billion |
| Net income | US$17.3 billion | US$20.1 billion | US$22.4 billion | US$14.4 billion | US$12.1 billion |
| Total assets | US$212.2 billion | US$245.7 billion | US$273.7 billion | US$298.3 billion | US$309.6 billion |
| Net cash provided by (used in) operating activities | US$22.3 billion | US$26.2 billion | US$29.1 billion | US$24.2 billion | US$19.7 billion |
| Net cash provided by (used in) investing activities | US$-10.4 billion | US$-28.5 billion | US$-15.6 billion | US$-20.5 billion | US$-8.7 billion |
| Net cash provided by (used in) financing activities | US$-7.5 billion | US$4.2 billion | US$-11.5 billion | US$-3.5 billion | US$-11.6 billion |
| Cash and cash equivalents | US$21.4 billion | US$23.4 billion | US$25.4 billion | US$25.3 billion | US$24.4 billion |
Revenue scale in the same industry
UnitedHealth Group
Insurance carriers: 54 companies · revenue · largest first・FY Dec 2025・Consolidated・Disclosed
- 1 UnitedHealth GroupThis company US$447.6B
- 2 Berkshire Hathaway US$371.4B
- 3 The Cigna Group US$274.9B
- … 51 companies
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$3.6 billion | Consolidated | Disclosed |
| Cash and cash equivalents | US$24.4 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$-11.6 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$-8.7 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$19.7 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$4.4 billion | Consolidated | Disclosed |
| Dividends paid | US$7.9 billion | Consolidated | Disclosed |
| Stockholders' equity (including non-controlling interests) | US$100.1 billion | Consolidated | Disclosed |
| Non-controlling interests | US$6.0 billion | Consolidated | Disclosed |
| Net sales | US$447.6 billion | Consolidated | Disclosed |
| Operating income | US$19.0 billion | Consolidated | Disclosed |
| Net income | US$12.1 billion | Consolidated | Disclosed |
| Total assets | US$309.6 billion | Consolidated | Disclosed |
| Purchase of treasury stock | US$5.5 billion | Consolidated | Disclosed |
| Operating margin | 4.2% | Consolidated | Calculated |
| Net assets to total assets | Cannot be calculated | Not applicable | Not calculated (no stockholders' equity in this year's 10-K) |
| Net margin | 2.7% | Consolidated | Calculated |
| Return on equity | Cannot be calculated | Not applicable | Not calculated (no stockholders' equity in this year's 10-K) |